Northwest Bioth Cmn (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,954 | -22,331 | -21,247 | -1,395 | -9,937 |
| Depreciation Amortization | 1,344 | 390 | 5,769 | 2,025 | 2,971 |
| Accounts receivable | 1 | -1 | 3 | 72 | -64 |
| Accounts payable and accrued liabilities | N/A | 2,866 | 582 | -810 | N/A |
| Other Working Capital | 7,533 | 3,361 | -2,165 | -766 | 2,225 |
| Other Operating Activity | 13,399 | 128 | 2,457 | -6,056 | 621 |
| Operating Cash Flow | $-4,677 | $-15,587 | $-14,601 | $-6,930 | $-4,184 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -389 | -24 | 17 | 54 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -4 |
| Investing Cash Flow | $-2 | $-389 | $-24 | $17 | $50 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,360 | 8,150 | 2,600 | 1,800 | 3,050 |
| Debt Repayment | N/A | N/A | -5,052 | -23 | -92 |
| Common Stock Issued | 1,393 | 1 | 25,886 | 5,091 | 4 |
| Dividend Paid | N/A | N/A | -1,251 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 1,276 |
| Financing Cash Flow | $4,753 | $8,151 | $22,183 | $6,868 | $4,238 |
| Exchange Rate Effect | -25 | -20 | -4 | N/A | N/A |
| Beginning Cash Position | 16 | 7,861 | 307 | 352 | 248 |
| End Cash Position | 65 | 16 | 7,861 | 307 | 352 |
| Net Cash Flow | $49 | $-7,845 | $7,554 | $-45 | $104 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,677 | -15,587 | -14,601 | -6,930 | -4,184 |
| Capital Expenditure | -2 | -397 | -24 | N/A | -43 |
| Free Cash Flow | -4,679 | -15,984 | -14,625 | -6,930 | -4,227 |